Search for: "Novartis International AG"
Results 61 - 80
of 120
Sort by Relevance
|
Sort by Date
9 Jan 2014, 1:37 pm
We’ve covered a lot of topics since we started DDLaw in late 2006. [read post]
21 Jul 2013, 5:38 pm
Lipimile, Director & Chief Executive Officer, COMESA Competition Commission • Ali Haddou Ruiz, Executive Secretary, The Federal Competition Commission, Mexico • Michele Piergiovanni, Case Manager, European Commission Merger Control Unit, European Commission • Carel Maske, Senior Attorney, Antitrust, Microsoft EMEA • Martin Commons, Senior Competition/Antitrust Counsel, BHP Billiton • Joerg Haering, Division General Counsel Legal & Compliance, Siemens • Susan… [read post]
26 Jun 2013, 6:43 am
It is therefore insufficient: see Novartis AG v Johnson & Johnson Medical Ltd [2010] EWCA Civ 1039, [2011] ECC 10 at [77]. [read post]
28 Apr 2013, 9:32 am
* * * The following allegations are based on the government’s complaint filed in the Southern District of New York: Novartis, a pharmaceutical company headquartered in East Hanover, N.J., is a subsidiary of Novartis AG, an international pharmaceutical company headquartered in Basel, Switzerland. [read post]
7 Apr 2013, 9:37 pm
Noven Pharmaceuticals Inc. et al. 1:13-cv-00527; filed April 3, 2013 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; Novartis International Pharmaceutical Ltd.; LTS Lohmann Therapie-Systeme AG • Defendants: Noven Pharmaceuticals Inc.; Noven Therapeutics LLC; Hisamitsu Pharmaceutical Co. [read post]
10 Feb 2013, 8:30 am
Novartis AG is also recalling about 185 lots of cough syrup. [read post]
9 Feb 2013, 4:04 pm
The extent to which the United States participates in the construction of these autonomous international systems may suggest the direction in which government policy may be moving away from the traditional consensus of corporate responsibility to something perhaps entirely new. [read post]
19 Oct 2012, 6:13 pm
Assets related to four of the markets would be divested to Sandoz International GmbH, a subsidiary of Novartis AG. [read post]
10 Jan 2012, 3:00 am
In 2010, Novartis International AG, a major manufacturer of generic prescription drugs, recorded sales of $46.806 billion. [read post]
10 Oct 2011, 12:31 am
"We can now confirm that the deadline to submit comments on Case C- 442/11 Novartis AG v Actavis UK Limited is 14 October 2011" writes the UK Intellectual Property Office, which adds "If you would like to comment on this case please e-mail policy@ipo.gsi.gov.uk before 14 October 2011". [read post]
14 Aug 2011, 9:11 am
Brief for Amici Curiae New England Journal of Medicine, Journal of the American Medical Association, and Annals of Internal Medicine in Support of Respondent, Daubert v. [read post]
29 Jun 2011, 3:34 am
(Patent Docs) Deferacirox – India: Cipla wins pre grant opposition (593/CHENP/2005): Novartis v. [read post]
29 Apr 2011, 7:43 am
Novartis Corp. [read post]
29 Mar 2011, 9:19 pm
New pharmaceutical compulsory licenses proposed for patented medicines (Patentology) (ipwars) Canada: Election drum beats the life out of Access to Medicines Bill (IP Osgoode) EU opines on the patentability of human embryonic stem cells: Brüstle v Greenpeace (Kluwer Patent Blog) (IPBiz) EU: In the ECJ this week: Case C-195/09 Synthon v Merz Pharma and Case C-427/09 Generics (UK) v Synaptech (The SPC Blog) India: The production of generic drugs in India: A new trade agreement with the EU would… [read post]
31 Jan 2011, 3:19 am
Coflexip v Stolt (PatLit) Fuzzy boundaries, woolly limitations and over-broad claims: a case-study in insufficiency: Novartis AG & Cibavision AG v Johnson & Johnson (jiplp) ‘Where there is friendship, there is also fun’: President Bauer speaks to the IPKat (IPKat) PCC Page 13: Snails and Octopuses (PatLit) EWHC (Ch) – Galileo and the case of the ventilating hearing officer: Galileo International Technology LLC v European Union (formerly… [read post]
17 Nov 2010, 1:48 am
(Patent Baristas) A round up of international events – Access and Benefit Sharing Protocol; review of Para 6 system; concerns with ACTA’s compatibility with TRIPS(Spicy IP) Compromise UN protocol treaty against biopiracy adopted in Japan (IP Watch) (Innovation Law Blog) TRIPS Council discusses efficacy of ACTA, public health amendment (IP Watch) Altering genes in crops (IP Osgoode) Asia Pacific Pharmas moving away from generics (GenericsWeb) Belgium Commercial Court: No… [read post]
18 Oct 2010, 3:07 am
SEB S.A (Patently-O) (Inventive Step) (Filewrapper) New false marking bill introduced in the House (Patent Docs) (271 Patent Blog) (FDA Law Blog) UK: Court of Appeal gives guidance on enablement: Novartis AG & Cibavision AG v. [read post]
18 Oct 2010, 1:47 am
An estimated 95% of cases occur in Asia and Africa and up to 60% of cases are in children under 15 years of age. [read post]
6 Oct 2010, 4:22 am
(profitability through simplicity) US: Yeda Appeals Board decision favoring Abbott in TBP-II interference (Holman’s Biotech IP Blog) US: Jury finds Scruggs wilfully infringed Monsanto patents, awards at least $9 million in damages (Holman’s Biotech IP Blog) US: Marcy Kaptur’s bill to create a compulsory license for patented seeds: the Seed Availability and Competition Act of 2009 (KEI) US: Glaxosmithkline Biologicals seeks review of BPAI decision concerning isolated protein from B… [read post]
1 Oct 2010, 3:38 am
Court of Appeal (Civil Division) Novartis AG & Anor v Johnson & Johnson Medical Ltd & Anor [2010] EWCA Civ 1039 (29 September 2010) High Court (Administrative Court) MXL, R (on the application of) & Ors v Secretary of State for the Home Department [2010] EWHC 2397 (Admin) (30 September 2010) High Court (Chancery Division) Anfield (UK) Ltd v Bank of Scotland Plc & Ors [2010] EWHC 2374 (Ch) (24 September 2010) Shepherd v Williamson & Anor [2010] EWHC 2375… [read post]
